Platinum Priority – Editorial and Reply from AuthorsReferring to the article published on pp. 177–188 of this issueCXCL8, an Underestimated “Bad Guy” in Prostate Cancer
Referring to the article published on pp. 177–188 of this issue
Section snippets
Conflicts of interest
The author has nothing to disclose.
References (10)
- et al.
Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia
Am J Pathol
(2001) - et al.
Potentiation of inflammatory CXCL8 signalling sustains cell survival in PTEN-deficient prostate carcinoma
Eur Urol
(2013) - et al.
Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation
Carcinogenesis
(2008) - et al.
Nonapical and cytoplasmic expression of interleukin-8, CXCR1, and CXCR2 correlates with cell proliferation and microvessel density in prostate cancer
Clin Cancer Res
(2005) - et al.
Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer
Cancer Res
(2007)
There are more references available in the full text version of this article.
Cited by (8)
Chronic nitric oxide exposure induces prostate cell carcinogenesis, involving genetic instability and a pro-tumorigenic secretory phenotype
2022, Nitric Oxide - Biology and ChemistryCitation Excerpt :Etoposide treated RW/NO_LT and RW/NOw cells had reduced caspase-3 activation and reduced PARP cleavage as compared to treated control cells, illustrating that NO exposed cells were more resistant to treatment with DNA damaging agents and incurred less cell death via apoptosis, as shown by a decrease in caspase-3 activity in the RW/NOw etoposide treated cells. IL-6 and IL-8 have been previously reported to play a role in the transformation and increased survival of prostate cancer cells [43,64]. We have found that IL-6 and IL-8 mRNA are induced by acute exposure to NO, and further enhanced further with chronic exposure.
Chronic inflammatory mediators enhance prostate cancer development and progression
2015, Biochemical PharmacologyIn Prostate Cancer Cells Cytokines Are Early Responders to Gravitational Changes Occurring in Parabolic Flights
2022, International Journal of Molecular SciencesCXCL1-LCN2 paracrine axis promotes progression of prostate cancer via the Src activation and epithelial-mesenchymal transition
2019, Cell Communication and Signaling
Copyright © 2012 European Association of Urology. Published by Elsevier B.V. All rights reserved.